Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor-Positive Breast Cancer.
Am Soc Clin Oncol Educ Book
; 42: 1-13, 2022 Apr.
Article
en En
| MEDLINE
| ID: mdl-35623026
Endocrine therapy has undergone major changes in the past few years, and is no longer a "one- size- fits- all" prescription. This article discussed some of the new developments and directions.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
Límite:
Female
/
Humans
Idioma:
En
Revista:
Am Soc Clin Oncol Educ Book
Año:
2022
Tipo del documento:
Article
País de afiliación:
Francia
Pais de publicación:
Estados Unidos